Literature DB >> 21183268

Placental pathology in fetal growth restriction.

Natalija Vedmedovska1, Dace Rezeberga, Uldis Teibe, Ivars Melderis, Gilbert G G Donders.   

Abstract

OBJECTIVES: One of the causes of intrauterine fetal growth restriction (FGR) can be pathology of the placenta. The aim of this study was to compare macroscopic and microscopic changes of the placentas from intrauterine growth restricted fetuses with those from normally developed fetuses, in order to test the hypothesis that vascular damage due to decreased maternal vascular perfusion may be responsible for FGR. STUDY
DESIGN: Between May 2007 and December 2008 we performed detailed macroscopic and histological examination of singleton placentas of 50 consecutive neonates with fetal growth restriction (FGR group) and compared them to 50 normal fetuses, born next to an FGR case, as a control group.
RESULTS: Gestational age, birth weight, spontaneous delivery rate, mean weight of the placenta and the fetal-placental weight ratio were all lower in the FGR group than in the control group (p<0.05). Thickening of the villous trophoblastic basal membrane, incidence of villous infarction, presence of thrombi or haematomas and the incidence of villitis were more common in the FGR group than in the controls (p<0.05). There were, however, no significant differences in perivillous fibrin deposition, stromal fibrosis and cytotrophoblast proliferation between the groups. In FGR women who smoked, intervillous haematomas and villous infarction were more common (p<0.05) than in controls.
CONCLUSIONS: All macroscopic and microscopic pathological changes associated with FGR were directly linked to reduction of placental blood flow. As smoking is a main risk factor for these placental abnormalities these results emphasize the need to persuade women to quit smoking not only during pregnancy, but even better long before pregnancy.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21183268     DOI: 10.1016/j.ejogrb.2010.11.017

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  26 in total

1.  Does multiple gestation impact birthweight deficit from smoking?

Authors:  F A Okah; A A Oshodi; Y Liu; J Cai
Journal:  J Perinatol       Date:  2013-12-05       Impact factor: 2.521

2.  Prenatal diagnosis of a placental infarction hematoma associated with fetal growth restriction, preeclampsia and fetal death: clinicopathological correlation.

Authors:  Alma Aurioles-Garibay; Edgar Hernandez-Andrade; Roberto Romero; Faisal Qureshi; Hyunyoung Ahn; Suzanne M Jacques; Maynor Garcia; Lami Yeo; Sonia S Hassan
Journal:  Fetal Diagn Ther       Date:  2014-05-17       Impact factor: 2.587

3.  Maternal use of selective serotonin reuptake inhibitors (SSRI) during pregnancy-neonatal outcomes in correlation with placental histopathology.

Authors:  Michal Levy; Michal Kovo; Hadas Miremberg; Noa Anchel; Hadas Ganer Herman; Jacob Bar; Letizia Schreiber; Eran Weiner
Journal:  J Perinatol       Date:  2020-01-27       Impact factor: 2.521

Review 4.  Perspective: L-arginine and L-citrulline Supplementation in Pregnancy: A Potential Strategy to Improve Birth Outcomes in Low-Resource Settings.

Authors:  Andrea M Weckman; Chloe R McDonald; Jo-Anna B Baxter; Wafaie W Fawzi; Andrea L Conroy; Kevin C Kain
Journal:  Adv Nutr       Date:  2019-09-01       Impact factor: 8.701

Review 5.  Trophoblast lineage-specific differentiation and associated alterations in preeclampsia and fetal growth restriction.

Authors:  Omar Farah; Calvin Nguyen; Chandana Tekkatte; Mana M Parast
Journal:  Placenta       Date:  2020-02-13       Impact factor: 3.481

6.  Associations Between the Features of Gross Placental Morphology and Birthweight.

Authors:  Alexa A Freedman; Carol J Hogue; Carmen J Marsit; Augustine Rajakumar; Alicia K Smith; Robert L Goldenberg; Donald J Dudley; George R Saade; Robert M Silver; Karen J Gibbins; Barbara J Stoll; Radek Bukowski; Carolyn Drews-Botsch
Journal:  Pediatr Dev Pathol       Date:  2018-07-16

7.  Placental pathology in pregnancies complicated by fetal growth restriction: recurrence vs. new onset.

Authors:  Michal Levy; David Alberti; Michal Kovo; Letizia Schreiber; Eldar Volpert; Liron Koren; Jacob Bar; Eran Weiner
Journal:  Arch Gynecol Obstet       Date:  2020-04-24       Impact factor: 2.344

Review 8.  Metabolomics in Prenatal Medicine: A Review.

Authors:  Giovanni Monni; Luigi Atzori; Valentina Corda; Francesca Dessolis; Ambra Iuculano; K Joseph Hurt; Federica Murgia
Journal:  Front Med (Lausanne)       Date:  2021-06-25

9.  Reduced placental telomere length during pregnancies complicated by intrauterine growth restriction.

Authors:  Jérôme Toutain; Martina Prochazkova-Carlotti; David Cappellen; Ana Jarne; Edith Chevret; Jacky Ferrer; Yamina Idrissi; Fanny Pelluard; Dominique Carles; Brigitte Maugey-Laulon; Didier Lacombe; Jacques Horovitz; Jean-Philippe Merlio; Robert Saura
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

10.  miR-141 contributes to fetal growth restriction by regulating PLAG1 expression.

Authors:  Qiuqin Tang; Wei Wu; Xia Xu; Lu Huang; Qiong Gao; Huijuan Chen; Hong Sun; Yankai Xia; Jiahao Sha; Xinru Wang; Daozhen Chen; Qian Xu
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.